TRF Pharma's Series A Round

TRF Pharma raised a round of funding on March 23, 2009.

TRF Pharma is a hematology and oncology focused company, developing therapies to treat diseases of abberrant cell adhesion to endothelial (blood vessel) walls. Its programs in sickle cell disease and …

Articles about TRF Pharma's Series A Round: